44.49

0.74% -0.33

Xenon Pharmaceuticals Inc (XENE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$44.82

Aprire:

$45.2

Volume 24 ore:

1.17M

Relative Volume:

1.46

Capitalizzazione di mercato:

$3.44B

Reddito:

$13.17M

Utile/perdita netta:

$-199.06M

Rapporto P/E:

-16.24

EPS:

-2.74

Flusso di cassa netto:

$-156.53M

1 W Prestazione:

-0.78%

1M Prestazione:

+3.75%

6M Prestazione:

+33.32%

1 anno Prestazione:

+10.75%

Intervallo 1D:

$43.20

$45.23

Intervallo di 1 settimana:

$43.20

$46.36

Portata 52W:

$26.74

$46.60

Xenon Pharmaceuticals Inc Stock (XENE) Company Profile

Nome

Xenon Pharmaceuticals Inc

Settore

Healthcare (1131)

Industria

Biotechnology (631)

Telefono

(604) 484-3300

Indirizzo

200 - 3650 GILMORE WAY, BURNABY

Dipendente

327

Cinguettio

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

XENE's Discussions on Twitter

Confronta XENE con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
XENE Xenon Pharmaceuticals Inc	44.49	3.46B	13.17M	-199.06M	-156.53M	-2.74
VRTX Vertex Pharmaceuticals Inc	452.13	115.03B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	776.31	81.12B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	400.17	52.54B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	839.99	51.78B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	177.12	37.12B	447.02M	-1.18B	-906.14M	-6.1812

Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-09-03	Ripresa	Wells Fargo	Overweight
2025-05-07	Iniziato	Chardan Capital Markets	Buy
2025-02-11	Iniziato	Deutsche Bank	Buy
2024-10-10	Ripresa	Raymond James	Outperform
2024-10-01	Iniziato	H.C. Wainwright	Buy
2024-01-04	Iniziato	Citigroup	Buy
2023-12-08	Iniziato	Robert W. Baird	Outperform
2023-10-24	Ripresa	Cantor Fitzgerald	Overweight
2023-04-25	Iniziato	Cantor Fitzgerald	Overweight
2022-12-14	Iniziato	Goldman	Buy
2022-12-12	Iniziato	Cowen	Outperform
2022-11-28	Iniziato	Wells Fargo	Overweight
2022-10-19	Iniziato	Raymond James	Outperform
2022-08-29	Iniziato	BofA Securities	Buy
2022-07-21	Iniziato	JP Morgan	Overweight
2021-10-28	Iniziato	RBC Capital Mkts	Outperform
2020-10-02	Iniziato	SVB Leerink	Outperform
2020-07-21	Iniziato	Needham	Buy
2020-06-01	Ripresa	Jefferies	Buy
2020-03-25	Iniziato	Wedbush	Outperform
2020-01-08	Iniziato	William Blair	Outperform
2019-09-20	Iniziato	Guggenheim	Buy
2018-08-08	Reiterato	Stifel	Buy
2017-03-13	Iniziato	Jefferies	Buy
2016-10-21	Iniziato	Stifel	Buy
2016-09-26	Iniziato	Guggenheim	Buy
2016-04-14	Reiterato	Jefferies	Buy
2015-10-30	Ripresa	Jefferies	Buy
2014-12-02	Iniziato	Canaccord Genuity	Buy

Mostra tutto

Xenon Pharmaceuticals Inc Borsa (XENE) Ultime notizie

Jan 02, 2026

Xenon Pharmaceuticals (NASDAQ:XENE) CEO Ian Mortimer Sells 40,000 Shares - MarketBeat

Jan 02, 2026

Xenon Pharmaceuticals (NASDAQ:XENE) Shares Up 3.8% – Should You Buy? - Defense World

Jan 02, 2026

Jan 01, 2026

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat

Jan 01, 2026

Dec 31, 2025

Xenon Pharmaceuticals (NASDAQ:XENE) Trading 3.8% HigherHere's Why - MarketBeat

Dec 31, 2025

Dec 30, 2025

Analysts Conflicted on These Healthcare Names: Lifecore Biomedical (LFCR) and Xenon (XENE) - The Globe and Mail

Dec 30, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Novavax (NVAX), Xenon (XENE) and Biohaven Ltd. (BHVN) - The Globe and Mail

Dec 30, 2025

Dec 29, 2025

Commit To Purchase Xenon Pharmaceuticals At $32.50, Earn 25.8% Annualized Using Options - Nasdaq

Dec 29, 2025

Harbor Capital Advisors Inc. Has $450,000 Holdings in Xenon Pharmaceuticals Inc. $XENE - Defense World

Dec 29, 2025

Dec 28, 2025

Xenon announces new data on 48-month azetukalner OLE study data - MSN

Dec 28, 2025

Dec 26, 2025

Stifel reiterates Buy rating on Xenon Pharmaceuticals stock amid competitor setback - Investing.com Canada

Dec 26, 2025

Biohaven Misses The Mark In Depression Trial, Stock Falls - Sahm

Dec 26, 2025

Dec 25, 2025

Traders Purchase High Volume of Xenon Pharmaceuticals Put Options (NASDAQ:XENE) - MarketBeat

Dec 25, 2025

Dec 23, 2025

Why (XENE) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Dec 23, 2025

Dec 21, 2025

Can Xenon Pharmaceuticals Inc. stock deliver surprise earnings beatMarket Performance Summary & Stepwise Swing Trade Plans - bolumsonucanavari.com

Dec 21, 2025

Dec 20, 2025

Pullback Watch: How rising interest rates impact Xenon Pharmaceuticals Inc. stockMarket Sentiment Report & Growth Focused Stock Pick Reports - Улправда

Dec 20, 2025

Analysts Offer Insights on Healthcare Companies: Xenon (XENE) and 4D Molecular Therapeutics (FDMT) - The Globe and Mail

Dec 20, 2025

Dec 19, 2025

Returns Recap: Why Xenon Pharmaceuticals Inc. stock remains undervaluedJuly 2025 PostEarnings & Capital Efficient Trading Techniques - Улправда

Dec 19, 2025

Will Xenon Pharmaceuticals Inc. stock outperform tech sector in 20252025 Price Targets & Long Hold Capital Preservation Plans - Улправда

Dec 19, 2025

Can Xenon Pharmaceuticals Inc. stock resist sector downturns2025 Price Momentum & Precise Entry and Exit Recommendations - Улправда

Dec 19, 2025

Is Xenon Pharmaceuticals Inc. stock attractive for passive investorsPortfolio Update Report & AI Powered Buy and Sell Recommendations - Улправда

Dec 19, 2025

Dec 18, 2025

Why Xenon Pharmaceuticals Inc. stock remains undervalued2025 Market Overview & Fast Entry High Yield Stock Tips - Улправда

Dec 18, 2025

How rising interest rates impact Xenon Pharmaceuticals Inc. stockForecast Cut & High Conviction Buy Zone Alerts - Улправда

Dec 18, 2025

Xenon Pharmaceuticals: Derisked Pipeline Ahead Of Critical 2026 Phase 3 Readout (NASDAQ:XENE) - Seeking Alpha

Dec 18, 2025

Dec 13, 2025